View Post

Breast cancer breakthrough: Sarah Cannon discusses newly FDA-approved immunotherapy

Spring brings new hope and new beginnings, and for breakthroughs in cancer treatment, this season is off to a promising start. Earlier this month, the U.S. Food and Drug Administration (FDA) approved the first-ever immunotherapy (atezolizumab), in combination with chemotherapy, for the treatment of breast cancer. “Immunotherapy is a drug that we’ve been using in…
View Post
View Post

Dr. Erika Hamilton Appears on CNN to Discuss American Cancer Society’s New Breast Cancer Screening Guidelines

Dr. Erika Hamilton, Associate Director, Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute – the research arm of our global cancer enterprise, Sarah Cannon – was featured on CNN today regarding the American Cancer Society’s new screening guidelines just released. New screening guidelines state that women should begin getting mammograms at…
View Post
View Post

Sarah Cannon Blood Cancer Network’s Tulane Medical Center Receives International Accreditation

Did you know every three minutes someone is diagnosed with blood cancer? And that it takes a team approach to more effectively treat blood cancer? That is why Sarah Cannon, HCA’s global cancer enterprise, formed the Sarah Cannon Blood Cancer Network that brings together leading providers of blood cancer care for patients seeking treatment. HCA’s…
View Post
View Post

Sarah Cannon Expert Comments on Former President Carter’s Cancer Announcement

Dr. Johanna Bendell, Director of the GI Cancer Research Program and Associate Director of the Drug Development Program at Sarah Cannon Research Institute – the research arm of HCA’s global cancer enterprise Sarah Cannon – was featured on CNN, Fox News, and MSNBC Thursday morning to provide insight on former U.S. President Jimmy Carter’s recent…
View Post